Overview

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This research study is studying a possible therapy as a possible treatment for the consequences of Multiple Myeloma with renal insufficiency.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Amgen
Emory University
University Hospitals Cleveland Medical Center
University of Rochester
Treatments:
Denosumab